Impact of post-remission therapy in patients aged 65-70 years with de novo acute myeloid leukemia: a comparison of two concomitant randomized ALFA trials with overlapping age inclusion criteria.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples